Familial Primary Pulmonary Hypertension: all 352 studies

Page 4 of 4. Open to participants first (35), then studies with results posted, then the rest; newest registration first within each.

• A Multinational, Multicenter, Study to Assess the Efficacy and Safety of BPS-314d-MR in Subjects With Pulmonary Arterial Hypertension Currently Receiving Treatment With an Endothelin Receptor Antagonist and/or a Phosphodiesterase-5 InhibitorWithdrawnNCT01458236Phase 3
• Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)CompletedNCT01457781Phase 2
• Early Detection of Pulmonary Arterial Hypertension Using Cardiac Magnetic Resonance ImagingCompletedNCT01451255
• Registry for Pulmonary Hypertension in ChinaStatus unknownNCT01417338
• Safety, Tolerability, and PK Parameters of Sodium Nitrite Inhalation Solution in Healthy SubjectsCompletedNCT01409122Phase 1
• Responsiveness of Exercise Tests in Pulmonary Arterial HypertensionCompletedNCT01391104Not applicable
• Effects of Iloprost Treatment in Adult Patients With Pulmonary Arterial Hypertension Related to Congenital Heart DiseaseStatus unknownNCT01383083
• Efficacy of Ventavis Used in Real-life Setting.CompletedNCT01355380
• Evaluation of Metformin Activity in Addition to Conventional Treatment of Grade II or III Pulmonary Arterial Hypertension (PAH)WithdrawnNCT01352026Phase 2
• Endothelial Function in Patients With Pulmonary Arterial HypertensionCompletedNCT01317134Not applicable
• Iron Deficiency In Pulmonary HypertensionStatus unknownNCT01288651Phase 4
• Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl.CompletedNCT01265888Phase 2
• Beta-blockers in i-PAHStatus unknownNCT01246037Phase 1/2
• Modulating Effects of Lisinopril on Sildenafil Activity in Pulmonary Arterial Hypertension(PAH)( MELISSA)CompletedNCT01181284
• Tezosentan in Patients With Pulmonary Arterial HypertensionTerminatedNCT01094067Phase 2
• Tezosentan in Pulmonary Arterial HypertensionTerminatedNCT01077297Phase 2
• Post Marketing Observational Study in Patients With Pulmonary Arterial HypertensionCompletedNCT01066845
• Effect of BMPR-2 Gene Mutations on Hemodynamic Response by Iloprost Inhalation in Pulmonary Arterial HypertensionCompletedNCT01054105
• Ventavis® Registry ProtocolTerminatedNCT00902603
• Post-Marketing Surveillance of Ventavis® in Chinese Patients With Primary Pulmonary Hypertension (PPH)CompletedNCT00882947
• Open Label Access Study Of Sildenafil In Adult Patients With Pulmonary Arterial Hypertension Completing A1481244 StudyNo longer availableNCT00878943
• Study of Cicletanine for Pulmonary Arterial Hypertension (PAH)TerminatedNCT00832507Phase 2
• The Expression and Significance of MiRNACompletedNCT00806312
• Reversible Secondary Myelofibrosis or Clonal Myeloproliferative DisorderTerminatedNCT00722254
• Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc)TerminatedNCT00706082
• Safety and Feasibility of Autologous Endothelial Progenitor Cells Transplantation in Patients With Idiopathic Pulmonary Arterial HypertensionCompletedNCT00641836Not applicable
• Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With BosentanWithdrawnNCT00625469Phase 4
• Pulmonary Arterial Hypertension in Systemic SclerosisStatus unknownNCT00617487
• The Early Recognition of Pulmonary Arterial HypertensionCompletedNCT00609349Not applicable
• Pharmacogenomics in Pulmonary Arterial HypertensionWithdrawnNCT00593905
• Therapy of Pulmonary Arterial Hypertension (PAH) - Treatment With Sildenafil in Eisenmenger PatientsTerminatedNCT00586794Phase 3
• Biomarkers in the Diagnosis and Assessment of Pulmonary Arterial Hypertension (PAH)CompletedNCT00566423Not applicable
• Rehabilitation for Patients With Pulmonary Arterial HypertensionStatus unknownNCT00544726Not applicable
• Hemodynamic Response After Six Months of SildenafilStatus unknownNCT00483626Phase 4
• Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial HypertensionWithdrawnNCT00453414Phase 2
• Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)CompletedNCT00452218Phase 1
• 6R-BH4 Pulmonary Arterial Hypertension StudyCompletedNCT00435331Phase 1
• Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.CompletedNCT00423748Phase 3
• A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.CompletedNCT00423202Phase 3
• Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial HypertensionStatus unknownNCT00372346Not applicable
• Bosentan in Children With Pulmonary Arterial HypertensionCompletedNCT00319267Phase 3
• Effects of Tracleer (Bosentan) on Pulmonary Arterial Hypertension Related to Eisenmenger PhysiologyCompletedNCT00317486Phase 4
• Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial HypertensionCompletedNCT00257413Not applicable
• Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 YearsCompletedNCT00250640
• Genetic Research of Bone Morphogenetic Protein Receptor-II Gene in Taiwanese Patient With Primary Pulmonary HypertensionStatus unknownNCT00173537Not applicable
• Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension (IPAH)TerminatedNCT00120380Phase 4
• A Study of Aspirin and Clopidogrel in Patients With Idiopathic Pulmonary Arterial HypertensionCompletedNCT00105209Phase 2
• Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH)CompletedNCT00086463Phase 2
• Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial HypertensionCompletedNCT00080457Phase 3
• A Transition Study From Flolan® to Remodulin® in Patients With Pulmonary Arterial HypertensionCompletedNCT00058929Phase 4
• Phase IV Study of Chronic Infusional Epoprostenol for Severe Primary Pulmonary HypertensionCompletedNCT00004754Phase 4
• Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary HypertensionCompletedNCT00004497Phase 3

← Familial Primary Pulmonary Hypertension overview